AGPCNP - NU 641 (Women-
p p p p
s Health) Midterm Exam Q & S 2
p p p p p p p
024
Question 1 p 0/1
SerumpFSHpindirectlypmeasurespovarianpfunction,pwith
levelspofpFSHpindicatingp
normallypfunctioningpovaries.
ApLower
.
BpMedia
n
.p
CpHighe
r
.p
DpAbsen
t
.p
Question 2 1/1
p p
Endometrialp polypsp arep mostp commonlyp identifiedp by:
Ap Ap speculump exam
.
Bp Ap bimanualp exam
.
CpAp pappsmear
.
DpAptransvaginal
ultrasound
.
Question 3 1/1
p
Cliniciansp canp participate p inp primaryp sexualp violencep preventionp byp applyingp individualppreventi
onpskills,psuchpas:
Ap Challengingp behaviorsp inp othersp thatp promote
violence
.
Bp Engagingp inp healthyp professionalp andp personal
relationships
.
Cp Learningp top identifyp riskp factorsp forp sexuallyp abusive
behaviors
.
DpBp andp C
, AGPCNP - NU 641 (Women-
p p p p
s Health) Midterm Exam Q & S 2
p p p p p p p
024
.
Ep A,p B,p andp C
.
Question 4 1/1
p
Ap waitingp periodp of betweenp bariatricp surgeryp andp pregnancyp isp recommended.
, AGPCNP - NU 641 (Women-
p p p p
s Health) Midterm Exam Q & S 2
p p p p p p p
024
Ap 6-12
months
.p p
Bp6-18
months
.p p
Cp 12-24
months
.p p
Dp3-5p years
.
Question 5 p 1/1
Barriersp forp providersp relatedp top intimatep partnerp violencep screeningp include:
Ap Discomfortp withp thep topic
.
BpHavingptoop muchp powerp thatp mightp be
intimidating
.
Cp Timep constraints
.
DpApapn
dp C.
Ep A,p B,p andp C
.
Question 6 1/1
p
Hirsutismp isp definedp as:
ApExcessivep terminalp hairplosspin
women
.p p
BpExcessivep nailpgrowthp inpwomen
.
Cp Brittlep nailp growthp inp women
.
DpExcessivep terminalp hairp growthp in
women
.p p
Question 7 0/1
p
Ap pharmacologic p treatmentp forp patientsp withp Hydradenitis p Suppurativap (HI)p mayp include
ApClindamycin
, AGPCNP - NU 641 (Women-
p p p p
s Health) Midterm Exam Q & S 2
p p p p p p p
024
.
BpMinocycline
.
CpMetformin
p p p p
s Health) Midterm Exam Q & S 2
p p p p p p p
024
Question 1 p 0/1
SerumpFSHpindirectlypmeasurespovarianpfunction,pwith
levelspofpFSHpindicatingp
normallypfunctioningpovaries.
ApLower
.
BpMedia
n
.p
CpHighe
r
.p
DpAbsen
t
.p
Question 2 1/1
p p
Endometrialp polypsp arep mostp commonlyp identifiedp by:
Ap Ap speculump exam
.
Bp Ap bimanualp exam
.
CpAp pappsmear
.
DpAptransvaginal
ultrasound
.
Question 3 1/1
p
Cliniciansp canp participate p inp primaryp sexualp violencep preventionp byp applyingp individualppreventi
onpskills,psuchpas:
Ap Challengingp behaviorsp inp othersp thatp promote
violence
.
Bp Engagingp inp healthyp professionalp andp personal
relationships
.
Cp Learningp top identifyp riskp factorsp forp sexuallyp abusive
behaviors
.
DpBp andp C
, AGPCNP - NU 641 (Women-
p p p p
s Health) Midterm Exam Q & S 2
p p p p p p p
024
.
Ep A,p B,p andp C
.
Question 4 1/1
p
Ap waitingp periodp of betweenp bariatricp surgeryp andp pregnancyp isp recommended.
, AGPCNP - NU 641 (Women-
p p p p
s Health) Midterm Exam Q & S 2
p p p p p p p
024
Ap 6-12
months
.p p
Bp6-18
months
.p p
Cp 12-24
months
.p p
Dp3-5p years
.
Question 5 p 1/1
Barriersp forp providersp relatedp top intimatep partnerp violencep screeningp include:
Ap Discomfortp withp thep topic
.
BpHavingptoop muchp powerp thatp mightp be
intimidating
.
Cp Timep constraints
.
DpApapn
dp C.
Ep A,p B,p andp C
.
Question 6 1/1
p
Hirsutismp isp definedp as:
ApExcessivep terminalp hairplosspin
women
.p p
BpExcessivep nailpgrowthp inpwomen
.
Cp Brittlep nailp growthp inp women
.
DpExcessivep terminalp hairp growthp in
women
.p p
Question 7 0/1
p
Ap pharmacologic p treatmentp forp patientsp withp Hydradenitis p Suppurativap (HI)p mayp include
ApClindamycin
, AGPCNP - NU 641 (Women-
p p p p
s Health) Midterm Exam Q & S 2
p p p p p p p
024
.
BpMinocycline
.
CpMetformin
